Abstract We have undertaken this study to identify the usefulness of polymerase chain reaction (PCR)-based analysis of DNA polymorphisms in the BclI/intron 18 and St14 variable number of tandem repeats (VNTR) loci for carrier detection and prenatal diagnosis of hemophilia A in the Korean population. We have analyzed these polymorphisms in members of 105 unrelated Korean families with severe hemophilia A. The observed heterozygosity rates for the BclI/intron 18 and St14 VNTR polymorphisms were 21.0% and 71.3%, respectively. The BclI/intron 18 polymorphism was less informative in Koreans when compared with Caucasians and Japanese. The allele frequencies for St14 VNTR in Koreans were different from those in Caucasians. Compared with Caucasians, there was a markedly higher occurrence of low molecular weight alleles in Koreans. The observed heterozygosity for the St14 VNTR polymorphism in combination with the BclI/intron 18 polymorphism was 81.9%. These two polymorphisms were applied to determine the carrier status of 107 women from 65 unrelated families, and to assess fetal status in 37 pregnancies. So far, we have experienced one case of misdiagnosis of carriership. Our study demonstrated that the PCR-based analysis of the BclI/intron 18 and St14 VNTR polymorphisms was useful in the carrier detection and prenatal diagnosis of hemophilia A in the Korean population.
Introduction
Carrier detection and prenatal diagnosis of hemophilia A has been greatly improved by molecular diagnosis through direct and indirect gene analysis. Although methods for the direct detection of pathogenic mutations such as factor VIII intron 22 gene inversions have been developed recently (Lakich et al. 1993; Pieneman et al. 1995) , indirect gene analysis using DNA polymorphisms still plays an important role in the carrier detection and prenatal diagnosis of hemophilia A. Many polymorphic markers within or near the factor VIII gene have been reported as being useful for the carrier detection and prenatal diagnosis of hemophilia A: BclI/intron 18 polymorphism (Gitschier et al. 1985) , XbaI/ intron 22 polymorphism (Wion et al. 1986 ), intron 13/22 dinucleotide repeat polymorphisms (Lalloz et al. 1991) , and extragenic St14 variable number of tandem repeats (VNTR) located at 4 cM from the factor VIII gene (Oberle et al. 1985; Richards et al. 1991) . The polymerase chain reaction (PCR) has made DNA polymorphism analysis simpler and more rapid for clinical applications than Southern blot analysis, and it can be applied in the analysis of most polymorphisms linked to the factor VIII gene. However, the analysis of the XbaI polymorphism by PCR has not been reliable, because the homologous non-factor VIII region on X chromosome is also coamplified (Kogan et al. 1987) .
The allele frequencies in a given factor VIII restriction fragment length polymorphism (RFLP) differ significantly in various ethnic groups (Chan et al. 1988; Graham et al. 1990 ). Thus, the clinical usefulness of a DNA polymorphism should be determined according to ethnicity. In this study, we examined whether PCR-based analysis of DNA polymorphisms in the BclI/intron 18 and St14 VNTR loci was useful for carrier detection and prenatal diagnosis of hemophilia A in the Korean population.
Subjects and methods

Subjects
BclI/intron 18 and St14 VNTR polymorphisms were analyzed in 182 unrelated subjects (105 mothers and 77 fathers) in 105 unrelated families with severe hemophilia A. These two polymorphisms were utilized to determine carrier status in 107 women from 65 unrelated families. We performed prenatal diagnosis in 40 pregnancies. All subjects were Korean, and were enrolled in this study after informed consent was obtained.
Sample preparations
Genomic DNA was extracted from leukocytes obtained from the subjects' peripheral blood by one of two methods: (1) a modified phenol/chloroform extraction procedure (Sambrook et al. 1989) , or (2) with Wizard genomic DNA purification kits (Promega, Madison, WI, USA). Factor VIII coagulant (FVIII:C) levels were measured by activated partial thromboplastin time, using a chromogenic assay (Dade Behring, Newark, NJ, USA) with Electra 1000C (MLA; New York, NY, USA). Chorion villous samples were obtained by the transvaginal route under ultrasound guidance at 10 to 12 weeks of gestation. Transabdominal amniocentesis was performed between 16 and 18 weeks of gestation. For the prenatal diagnosis, DNA was extracted from either chorionic villi or amniocytes. Both chromosomal analysis and PCR with Y-chromosome-specific primer sets (Kogan et al. 1987) were used for fetal sexing.
Factor VIII gene analysis
The BclI/intron 18 and St14 VNTR polymorphisms were analyzed by PCR. PCR was performed as described previously (Sarkar et al. 1989; Richards et al. 1991) , with minor modifications. PCR was performed by adding 0.1-0.5 mg of DNA to 50 ml PCR reaction mixture (final concentration; 50 mM KCl, 10 mM Tris HCl (pH 8.3), 1.5 mM MgCl 2 , 0.01% (w/v) gelatin, 50 mM each dNTP, and 0.5 mM of each primer and 1 U of Taq polymerase).
Oligonucleotides were as follows: primers 5Ј-ATGTGT TCACTGTACGA-3Ј and 5Ј-AATATCTTGGGATGG AC-3Ј for the BclI region (Sarkar et al. 1989 ) and primers 5Ј-GGCATGTCATCACTTCTCTCATGTT-3Ј and 5Ј-CACCACTGCCCTCACGTCACTT-3Ј for the St14 VNTR region (Richards et al. 1991) .
After 1min at 94°C for initial denaturation, 30 (St14 VNTR) or 35 (BclI) cycles of PCR were performed (denaturation, 30s at 94°C; annealing, 1 min at 55°C; extension, 2min at 72°C) with an automated thermal cycler (PE Applied Biosystems, Forster City, CA, USA). For the BclI polymorphism, 10 ml of amplified product was digested with BclI restriction enzyme at 50°C for 2-4h and submitted to 3%-4% agarose gel electrophoresis and stained with ethidium bromide. For St14 VNTR, amplified products underwent 1.5% agarose gel electrophoresis and were stained with ethidium bromide.
Cordocentesis
For prenatal diagnosis, cordocentesis was performed at 18-24 weeks of gestation in the following instances, with parental consent: (1) when the linkage analysis was not informative in pregnancies with a male fetus; (2) to confirm the disease status in an affected male fetus diagnosed by molecular analysis; and (3) when the parents strongly desired to confirm fetal status by fetal blood coagulation study although molecular diagnosis suggested an unaffected fetus.
Results
Factor VIII activities in obligate carriers
Factor VIII activity was measured in 83 obligate carriers of severe hemophilia A. Factor VIII activity ranged from 7.9% to 125%, with a median value of 44.9%.
Heterozygosity rate of each RFLP
The expected rate of heterozygosity of the BclI/intron 18 RFLP, calculated from allele frequencies of 84.7% and 15.3%, was 25.9% (Table 1) . Twenty-two of the 105 unrelated women (21.0%) studied showed a heterozygous pattern for the BclI/intron 18 RFLP.
The PCR for St14 VNTR in 182 unrelated individuals Carrier detection
The determination of carrier status was undertaken in 107 at-risk women from 65 unrelated families, in whom linkage analysis with BclI/intron 18 RFLP or St14 VNTR was possible. Of 54 women from 35 families with a known family history of hemophilia A, 27 women were diagnosed as carriers, and 27 women as non-carriers. Of 53 women from 30 families with sporadic hemophilia, carriership was excluded in 24 women, and 29 women were diagnosed as having a possibility of carriership.
Since the beginning of this study in 1994, we have experienced, so far, one case of misdiagnosis of carriership among 107 subjects assessed. The patient had a known family history, and was diagnosed as a non-carrier by analysis of the St14 VNTR polymorphism. However, the BcII polymorphism was uninformative in that subject. We established her carrier status after her daughter's delivery of a hemophiliac. Repeated molecular analysis of the St14 VNTR polymorphism in that family showed the same result as in the initial study. Therefore, we suspect that the misdiagnosis may have been caused by recombination between the St14 VNTR region and the factor VIII gene.
Prenatal diagnosis
We attempted 37 prenatal diagnoses in 32 women, using the two polymorphisms described above (Table 3) : 10 women were obligate carriers; 7 were diagnosed carriers with a family history; and 15 women were suspected carriers without a family history. Fetal sex was determined by chromosomal analysis of either amniocytes or chorionic villi.
Of 20 prenatal diagnoses in the 17 women with a family history of hemophilia A, 10 fetuses were diagnosed as normal males, 5 as normal females, and 4 as carriers. One fetus was diagnosed as an affected male by molecular analysis, which was confirmed by measuring factor VIII activity in fetal blood by cordocentesis (case 1 in Table 4 ). Of 17 prenatal diagnoses in the 15 women without a family history, 7 fetuses were diagnosed as normal males, 1 as a normal female, and 6 as carriers. Three fetuses were diagnosed as affected males; 2 (cases 2 and 3 in Table 4 ) diagnoses were confirmed by cordocentesis, and for the third fetus, the mother elected to terminate the pregnancy without confirmation by cordocentesis. In seven unaffected males diagnosed by molecular analysis (cases 4-10 in Table  4 ) the diagnoses were also confirmed by cordocentesis. Of the fetuses subjected to prenatal diagnosis performed above, no infant or child has been found, until now, to have any hemorrhagic manifestation or abnormal factor VIII activity after birth.
We performed prenatal diagnosis by cordocentesis in three additional male fetuses (cases 11-13 in Table 4 ). The carriership of the mothers could not be determined by linkage analysis. Factor VIII activity of fetal blood in these three subjects was within the normal range.
Four male fetuses (cases 14-17 in Table 4 ) whose mothers were diagnosed as non-carriers by molecular analysis underwent cordocentesis at the request of the parents, and showed normal factor VIII activity in cord blood. 
Discussion
Our study showed that the BclI/intron 18 and St14 VNTR polymorphisms were useful in the carrier detection and prenatal diagnosis of hemophilia A in the Korean population, and that the combination of these two polymorphisms made the molecular diagnosis of hemophilia A possible in about 80% of the Korean subjects investigated. The allele frequencies and the heterozygosity rate for the BclI polymorphism in Koreans were somewhat different from those found in Caucasians or Japanese. The heterozygosity rate for the BclI polymorphism has been reported to be 36%-42% in Caucasians (Gitschier et al. 1985; Salle et al. 1990 ), 42% in Japanese (Suehiro et al. 1988) , and 14%-30% in Chinese (Chan et al. 1988; Salle et al. 1990 ). Thus, the BclI polymorphism was less informative in Koreans (25.9%) when compared with Caucasians or Japanese, but it has similar heterozygosity in Koreans and Chinese.
Analysis of the XbaI polymorphism by Southern blot is known to be very informative in Caucasians, Chinese, and Japanese, giving a heterozygosity rate of 43%-49% (Wion et al. 1986; Chan et al. 1988; Suehiro et al. 1988; Salle et al. 1990 ). However, analysis of the XbaI polymorphism by PCR is not reliable, because the homologous nonfactor VIII region on the X chromosome, which, for the most part, does not contain the XbaI restriction site, is also coamplified (Kogan et al. 1987) . This problem of coamplification has led us to abandon analysis of the XbaI polymorphism by PCR in the carrier detection and prenatal diagnosis of the hemophilia A.
Southern blot analysis of TaqI/St14 (DXS52) VNTR reveals a polymorphic system comprising at least ten allelic fragments, with an ethnic variation in allele frequencies. This TaqI/St14 RFLP gave a heterozygosity rate of over 80% in Caucasians (Oberle et al. 1985; Janco et al. 1986; Janco et al. 1987) , 76% in Japanese (Suehiro et al. 1988) , and 85% in Chinese (Chan et al. 1988) .
Recently, PCR analysis of St14 VNTR has been introduced for the rapid analysis and discrimination of closely sized alleles (Richards et al. 1991) . However, there have been few reports on this subject to date. Richards et al. (1991) have found 14 alleles in Caucasians, ranging from 700 bp to 3000 bp. We revealed 15 alleles in the Korean population, ranging from 700 bp to 2890bp. The expected heterozygosity rate of 78% in Koreans was comparable to that found in Japanese and Chinese by Southern blot analysis (Chan et al. 1988; Suehiro et al. 1988) .
Compared with Caucasians, there was a markedly higher occurrence of low molecular weight alleles in Koreans. The most frequent allele in Koreans was 700 bp in size, while it was 1690 bp in size in Caucasians (Richards et al. 1991) . The allele frequencies found in Koreans were similar to those found in the Chinese population (Wang et al. 1995) , in which the most frequent allele was 700 bp.
St14 VNTR is a highly informative marker in the molecular diagnosis of hemophilia A, but it carries a risk of about 4% recombination leading to misdiagnosis (Gitschier et al. 1991) . In the course of this study, we experienced one case of misdiagnosis using St14 VNTR analysis. This type of misdiagnosis, due to the use of extragenic markers, can be prevented by the use of other intragenic markers, such as intron 13/22 dinucleotide repeat polymorphisms.
The combination of the BclI polymorphism and TaqI/ St14 determined by Southern blot analysis in the Italian population showed that 91% of obligate carriers were heterozygous for one or both markers (Pecorara et al. 1987) . Our study disclosed that the combined use of these two polymorphic markers by PCR gave a heterozygosity rate of 81.9% in the Korean population.
Besides the two polymorphisms we have analyzed in this study, we have recently started to analyze intron 13/22 dinucleotide repeat polymorphisms and factor VIII gene inversion in a Korean population. Our preliminary study showed that intron 13/22 dinucleotide repeat polymorphisms had an observed heterozygosity of about 80%, and that factor VIII gene inversion was found in about 40% of patients with severe hemophilia A (unpublished results). These preliminary data are consistent with other reports, in the Caucasian population (Lalloz et al. 1991; Lakich et al. 1993; Windsor et al. 1994) . Therefore, the useful markers for carrier detection and prenatal diagnosis of hemophilia A in the Korean population are thought to be the BclI/ intron 18 polymorphism, intron 13/22 dinucleotide repeat polymorphisms, factor VIII gene inversion, and St14 VNTR.
Some investigators have reported factor VIII levels in cord blood during the midtrimester (Mibashan et al. 1979; Mibashan et al. 1980; Forestier et al. 1988) . Forestier et al. (1988) reported normal factor VIII activity of 39 Ϯ 12% between 18 and 22 weeks of gestation. In our subjects, normal factor VIII activity ranged from 21% to 125% between 18 and 24 weeks of gestation. Mibashan et al. (1980) reported abnormal factor VIIIC levels of 1 to 3 U/dl, in ten fetuses from families with severe hemophilia A between 17 and 22 weeks of gestation, whereas normal values in that gestational period were 31 to 81 U/dl (mean, 44 U/dl). In this study, we found that values for factor VIII activity in affected fetuses were less than 5% in cord blood. It is recommended that centers involved in the prenatal diagnosis of hemophilia A have their own data on factor VIII levels in fetuses.
In conclusion, our study has shown that the PCR-based analysis of the BclI/intron 18 and St14 VNTR polymorphisms is useful in the carrier detection and prenatal diagnosis of hemophilia A in the Korean population.
